28,345,045 First Dose Vaccinations, 55.2% of Population... 10,990,000 Remaining Vaccine Doses (Comprehensive)

COVID-19 Vaccination Center. [Photo by Yonhap News]

[Asia Economy Reporter Lim Chun-han] As the proportion of people who have received at least one dose of the COVID-19 vaccine surpassed half of the population, about 600,000 people received their first dose and approximately 550,000 completed their second dose on the 27th.

According to the COVID-19 Vaccination Response Promotion Team (Promotion Team) on the 28th, 598,603 people received their first dose for the first time the previous day. The number of new first-dose recipients, which had been around 370,000 to 390,000 for three consecutive days from the 23rd to the 25th, significantly increased to over 590,000 for two consecutive days starting from the 26th, when vaccinations began for pre-registered young and middle-aged adults aged 18 to 49.

By vaccine type, the new first-dose recipients were 561,627 for Pfizer, 19,927 for AstraZeneca (AZ), 10,241 for Moderna, and 6,808 for Janssen. As of midnight, the cumulative number of first-dose recipients in the country reached 28,345,045, accounting for 55.2% of the total population (51,349,116 as of last December). The cumulative first-dose recipients surpassed the 50% mark as of 11 a.m. on the 21st.

Breaking down the cumulative first-dose recipients by vaccine, Pfizer accounts for 13,833,937, AstraZeneca 10,996,475, and Moderna 2,343,764. The cumulative number of Janssen vaccine recipients is 1,170,869. Since the Janssen vaccine requires only one dose, those vaccinated with Janssen are included in both the first and second dose counts. The number of people who completed the second dose reached 549,112, marking over 400,000 for five consecutive days from the 23rd to the previous day. By vaccine, AstraZeneca accounts for 488,912, Pfizer 52,776, Janssen 6,808, and Moderna 616. Although the number of AstraZeneca fully vaccinated individuals was counted as 521,631, 32,719 of them received the first dose of AstraZeneca and the second dose of Pfizer as a mixed vaccination.

The total number of people who completed both doses increased to 14,346,836, which is about 27.9% of the population. The cumulative number of fully vaccinated individuals by vaccine is 7,715,505 for AstraZeneca (including 1,402,140 mixed vaccinations), 5,394,788 for Pfizer, 65,674 for Moderna, and the rest are Janssen recipients.

For Pfizer vaccine, 46.5% of the total target population (29,738,753) received the first dose, and 18.1% completed the second dose. For AstraZeneca vaccine, 89.7% of the target population (12,264,204) received the first dose, and the second dose completion rate is 62.9%. For Moderna vaccine, 69.6% of the total target population (3,369,506) received the first dose, and the second dose completion rate is 1.9%. For Janssen vaccine, 94.4% of the target population (1,239,870) were vaccinated, excluding 69,001 people.

Looking at the vaccination status by target and institution, including nursing hospitals and facilities, hospital-level or higher medical institutions, vulnerable facilities, military personnel, and cases where vaccinations were administered by public health centers or respective institutions, the first-dose rate is 95.3%, and the second-dose rate is 77.6%. The first and second dose rates at nationwide entrusted medical institutions and vaccination centers are 59.0% and 28.3%, respectively.

COVID-19 Vaccination. [Image source=Yonhap News]

As of midnight, the remaining vaccine stock in the country totals 10,986,800 doses. By vaccine type, there are 5,678,400 doses of AstraZeneca, 3,445,800 doses of Pfizer, 1,402,000 doses of Moderna, and 462,400 doses of Janssen.

The number of people vaccinated with leftover vaccines through standby lists managed by medical institutions or social networking service (SNS) applications such as Naver and Kakao increased by 80,729 (39,694 from standby lists and 41,035 from same-day SNS reservations). This brings the cumulative number of leftover vaccine recipients to 3,497,707.

Currently, four types of vaccines?AstraZeneca, Pfizer, Janssen, and Moderna?are being administered domestically. AstraZeneca, Pfizer, and Moderna vaccines require two doses, while Janssen requires only one dose. The interval between the first and second doses varies slightly by vaccine type. AstraZeneca recommends an 8 to 12-week interval, Pfizer a 3-week interval, and Moderna a 4-week interval. However, reflecting uncertainties in vaccine supply, the Promotion Team is temporarily extending the interval for mRNA vaccines (Moderna and Pfizer) up to 6 weeks.

Pre-registration and vaccination for the key target group of those aged 40 and under in the third quarter are underway simultaneously. As of midnight, the reservation rate for the 18 to 49 age group was 68.3%, with 10,221,979 out of 14,970,446 total eligible individuals having made reservations. By age group, the reservation rate was highest among those in their 40s at 74.2%, followed by those in their 20s (68.3%), late teens (66.6%), and 30s (61.4%).

Those aged 18 to 49 who have not yet made a reservation can do so until 6 p.m. on the 18th of next month. Those who made reservations for dates after Chuseok but wish to change their schedule to between September 13 and 19 can rebook by midnight on the 2nd of next month. Vaccinations have been conducted sequentially at nationwide entrusted medical institutions and regional vaccination centers since the 26th. On the second day of vaccinations, 172,891 people aged 18 to 49 received their first dose. Vaccinations for those who made reservations until the 5th of next month will use the Pfizer vaccine, and thereafter, recipients will be notified individually of the vaccine type via text message depending on supply conditions.

This content was produced with the assistance of AI translation services.